Camylofin PCD Pharma Franchise Company

Cafoli Lifecare offers a Camylofin range of 3 formulations across tablets and syrup, manufactured in WHO-GMP certified facilities. Distributors serving gynaecology, obstetrics and general-practice prescribers can secure district-wise monopoly franchise rights for this antispasmodic molecule with full promotional support.

What is Camylofin?

Camylofin is an antispasmodic agent with combined anticholinergic and direct smooth-muscle relaxant action. It relaxes spasm of visceral smooth muscle and is used to relieve painful cramps of the gastrointestinal, biliary and genitourinary tracts, and notably to accelerate cervical dilatation and shorten labour when used in obstetrics. Reference: PubChem - Camylofin.

Available Forms

The Cafoli Camylofin portfolio includes oral Tablets and Syrup, often combined with paracetamol for spasmodic pain. Contact us for current pack presentations and combinations.

Therapeutic Applications

Camylofin is prescribed for abdominal colic and cramps, dysmenorrhoea, biliary and renal colic, and in obstetrics to aid cervical dilatation during labour. Prescribers include gynaecologists, obstetricians, physicians and general practitioners.

Why Camylofin is a High-Potential Molecule for Distributors

Camylofin has a distinctive obstetric niche - it is widely used on labour wards to shorten the first stage of labour - alongside routine use for colicky abdominal and menstrual pain. This dual role gives it steady institutional demand from maternity units plus everyday OPD antispasmodic sales, a combination few competing molecules match.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Camylofin
2. PubMed: camylofin in labour
3. PubMed: camylofin antispasmodic use